Vijaya Diagnostic Centre Limited (NSE:VIJAYA)
India · Delayed Price · Currency is INR 1,346.10
-14.10 (-1.04%)
Jul 31, 2026, 3:29 PM IST
Vijaya Diagnostic Centre Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 8,142 | 8,142 | 6,814 | 5,478 | 4,592 | 4,624 |
Revenue Growth | 19.49% | 19.49% | 24.39% | 19.29% | -0.68% | 22.73% |
Gross Profit Gross Profit Growth | 7,195 | 7,195 | 5,733 | 4,614 | 3,828 | 3,776 |
Operating Income Operating Income Growth | 2,451 | 2,451 | 2,026 | 1,639 | 1,203 | 1,510 |
Net Income Net Income Growth | 1,730 | 1,730 | 1,431 | 1,188 | 846.32 | 1,097 |
Earnings Per Share EPS Growth | 16.79 | 16.79 | 13.92 | 11.59 | 8.26 | 10.69 |
EPS Growth | 20.62% | 20.62% | 20.10% | 40.31% | -22.73% | 29.11% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 2,891 | 2,891 | 2,810 | 1,845 | 2,553 | 2,252 |
Total Debt Total Debt Growth | 4,226 | 4,226 | 3,196 | 2,592 | 2,476 | 1,835 |
Net Cash (Debt) Net Cash Growth | -1,335 | -1,335 | -385.81 | -746.58 | 77.56 | 416.88 |
Net Cash Growth | - | - | - | - | -81.40% | -46.92% |
Net Cash Per Share Net Cash Per Share Growth | -12.95 | -12.95 | -3.75 | -7.28 | 0.76 | 4.06 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 2,706 | 2,706 | 2,245 | 1,833 | 1,646 | 1,580 |
Capital Expenditures CapEx Growth | -1,827 | -1,827 | -955.53 | -879.64 | -1,248 | -1,223 |
Free Cash Flow Free Cash Flow Growth | 878.75 | 878.75 | 1,289 | 953.37 | 397.69 | 356.5 |
Free Cash Flow Growth | -31.84% | -31.84% | 35.23% | 139.73% | 11.55% | -63.44% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 88.37% | 88.37% | 84.14% | 84.23% | 83.35% | 81.66% |
Operating Margin | 30.10% | 30.10% | 29.74% | 29.92% | 26.20% | 32.66% |
Pretax Margin | 28.58% | 28.58% | 28.35% | 28.97% | 24.72% | 31.88% |
Profit Margin | 21.25% | 21.25% | 21.00% | 21.69% | 18.43% | 23.72% |
FCF Margin | 10.79% | 10.79% | 18.92% | 17.40% | 8.66% | 7.71% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 2.000 | 2.000 | 2.000 | 1.000 | 1.000 | 1.000 |
Dividend Per Share Growth | 100.00% | 0% | 100.00% | 0% | 0% | - |
Dividend Yield | 0.15% | 0.23% | 0.20% | 0.16% | 0.26% | 0.23% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 80.07 | 51.24 | 72.25 | 54.83 | 47.19 | 40.73 |
Forward PE | 64.29 | 44.12 | 55.50 | 46.11 | 41.16 | 37.63 |
P/FCF Ratio | 157.42 | 100.87 | 80.19 | 68.34 | 100.43 | 125.32 |
PS Ratio | 16.99 | 10.89 | 15.17 | 11.89 | 8.70 | 9.66 |